Source: Eur Respir J 2014; 44: 1408-1411
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Falzon Dennis, Zellweger Jean-Pierre, Migliori Giovanni Battista, Jaramillo Ernesto. Drug resistance and tuberculosis elimination in low-incidence countries. Eur Respir J 2014; 44: 1408-1411

Member's Comments

No comment yet.

Related content which might interest you: TB drug resistance in low-incidence countries Source: Eur Respir Mon 2012; 58: 111-123 Year: 2012 Drug resistant tuberculosis in Belarus Source: Eur Respir J 2003; 22: Suppl. 45, 519s Year: 2003 Drug resistance in pulmonary tuberculosis in Turkey Source: Eur Respir J 2004; 24: Suppl. 48, 657s Year: 2004 Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 Towards tuberculosis elimination: an action framework for low-incidence countries Source: Eur Respir J 2015; 45: 928-952 Year: 2015 Drug resistance in tuberculosis Source: Eur Respir J 2005; 25: 376-379 Year: 2005 Drug resistant tuberculosis in Odessa, Southern Ukraine: Beijing family strains prevalence and the role of prisons in drug resistant TB transmission Source: Eur Respir J 2006; 28: Suppl. 50, 290s Year: 2006 TB drug resistance in high-incidence countries Source: Eur Respir Mon 2012; 58: 95-110 Year: 2012 Mycobacterium tuberculosis drug resistance surveillance in Belarus Source: Eur Respir J 2005; 26: Suppl. 49, 199s Year: 2005 Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Resistance pattern for tuberculosis in Europe Source: Annual Congress 2009 - PG12 EU FP7 TB PAN-NET: Update in tuberculosis: advances in the management of drug resistant and multi-drug resistent tuberculosis cases Year: 2009 Drug resistance to tuberculosis in Karachi Source: Eur Respir J 2004; 24: Suppl. 48, 655s Year: 2004 Surveillance of M. tuberculosis drug resistance in Russia Source: Eur Respir J 2001; 18: Suppl. 33, 513s Year: 2001 Drug resistance among new TB cases and relapses Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011 Primary drug resistance against mycobacterium tuberculosis in a high burden country Source: Eur Respir J 2006; 28: Suppl. 50, 587s Year: 2006 Multidrug resistance of M. tuberculosis and its infuence on treatment efficiency of new detected patients with pulmonary tuberculosis in penitentiary institutions of Belarus Source: Eur Respir J 2007; 30: Suppl. 51, 272s Year: 2007 Comparison of tuberculosis surveillance systems in low-incidence industrialised countries Source: Eur Respir J 2008; 32: 1616-1624 Year: 2008 Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden country Source: Eur Respir J, 57 (6) 2002544; 10.1183/13993003.02544-2020 Year: 2021 Moving towards tuberculosis elimination: a call for action from Italy and a possible model for other low tuberculosis incidence countries Source: Eur Respir J , 49 (2) 1602242; DOI: 10.1183/13993003.02242-2016 Year: 2017 Multidrug-resistant and extensively drug resistance tuberculosis has a strong public health and economical impact in the Republic of Moldova Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013